Dr. Hakanson, an anesthesiologist, has more than 16 years of experience in medical affairs, market access and health economic research. He most recently served as the vice president and head of health economics & outcomes research for U.S. medical and drug regulatory affairs at Novartis. He has also previously worked as vice president of healthcare access at Bristol-Myers Squibb.
Dr. Hakanson is a diplomat of the American Board of Anesthesiology and American Society of Anesthesiologists.
Otonomy is a clinical-stage biopharmaceutical company focusing on the development and commercialization of therapies for diseases and disorders of the ear.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.